Effect of bioimpedance body composition analysis on function of implanted cardiac devices

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 6, 2012, Pages 681-684

  Buch, Eric ^a   Bradfield, Jason ^a   Larson, Tianne ^b   Horwich, Tamara ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

Bioimpedance analysis; Body composition analysis; Device interaction; Heart failure; Implantable cardioverter defibrillator

Indexed keywords

ADULT; AGED; ARTICLE; BIOELECTRICAL IMPEDANCE ANALYSIS; BODY COMPOSITION; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL ARTICLE; DEFIBRILLATOR; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INCIDENCE; MALE; SHOCK; TELEMETRY;

ARTIFACTS; BODY COMPOSITION; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PLETHYSMOGRAPHY, IMPEDANCE;

EID: 84861971215     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03377.x     Document Type: Article

References (17)

1. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: Calendar year 2009 - a World Society of Arrhythmia's project. Pacing Clin Electrophysiol 2011; 34:1013-1027.
2. Jaffrin MY. Body composition determination by bioimpedance: An update. Curr Opin Clin Nutr Metab Care 2009; 12:482-486.
3. Biospace Web site. Available at: http://www.biospaceamerica.com/Customer/ faq.html (Accessed January 6, 2012).
4. Cornier MA, Despres JP, Davis N, Grossniklaus DA, Klein S, Lamarche B, Lopez-Jimenez F, et al. Assessing adiposity: A scientific statement from the American Heart Association. Circulation 2011; 124:1996-2019.
5. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gomez J, Lilienthal Heitmann B, et al. Bioelectrical impedance analysis-part II: Utilization in clinical practice. Clin Nutr 2004; 23:1430-1453. (Pubitemid 39517638)
6. Hayes DL, Wang PJ, Reynolds DW, Estes M 3rd, Griffith JL, Steffens RA, Carlo GL, et al. Interference with cardiac pacemakers by cellular telephones. N Engl J Med 1997; 336:1473-1479. (Pubitemid 27215161)
7. Webster G, Jordao L, Martuscello M, Mahajan T, Alexander ME, Cecchin F, Triedman JK, et al. Digital music players cause interference with interrogation telemetry for pacemakers and implantable cardioverter-defibrillators without affecting device function. Heart Rhythm 2008; 5:545-550.
8. Seidman SJ, Brockman R, Lewis BM, Guag J, Shein MJ, Clement WJ, Kippola J, et al. In vitro tests reveal sample radiofrequency identification readers inducing clinically significant electromagnetic interference to implantable pacemakers and implantable cardioverter-defibrillators. Heart Rhythm 2010; 7:99-107.
9. Holmgren C, Carlsson T, Mannheimer C, Edvardsson N. Risk of interference from transcutaneous electrical nerve stimulation on the sensing function of implantable defibrillators. Pacing Clin Electrophysiol 2008; 31:151-158. (Pubitemid 351190106)
10. Dubner S, Dubner Y, Rubio H, Goldin E. Electromagnetic interference from wireless video-capsule endoscopy on implantable cardioverter-defibrillators. Pacing Clin Electrophysiol 2007; 30:472-475. (Pubitemid 46596122)
11. Foo D, Walker BD, Kuchar DL, Thorburn CW, Tay A, Hayward CS, Macdonald P, et al. Left ventricular mechanical assist devices and cardiac device interactions:An observational case series. Pacing Clin Electrophysiol 2009; 32:879-887.
12. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001; 38:789-795.
13. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997; 349:1050-1053. (Pubitemid 27158249)
14. Oreopoulos A, Ezekowitz JA, McAlister FA, Kalantar-Zadeh K, Fonarow GC, Norris CM, Johnson JA, et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc 2010; 85:609-617.
15. Oreopoulos A, Kalantar-Zadeh K, McAlister FA, Ezekowitz JA, Fonarow GC, Johnson JA, Norris CM, et al. Comparison of direct body composition assessment methods in patients with chronic heart failure. J Card Fail 2010; 16:867-872.
16. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gomez JM, Heitmann BL, et al. Bioelectrical impedance analysis - part I: Review of principles and methods. Clin Nutr 2004; 23:1226-1243. (Pubitemid 39243041)
17. Castillo Martinez L, Colin Ramirez E, Orea Tejeda A, Asensio Lafuente E, Bernal Rosales LP, Rebollar Gonzalez V, Narvaez David R, et al. Bioelectrical impedance and strength measurements in patients with heart failure: Comparison with functional class. Nutrition 2007; 23:412-418. (Pubitemid 46670699)